Reply to Ching-Pin et al
- PMID: 39445698
- DOI: 10.14309/ajg.0000000000003102
Reply to Ching-Pin et al
References
-
- Ching-Pin L, Kuo P, Cheng-Chung Wei J. Addressing additional limitations in the study on small intestine cancer risk in patients with inflammatory bowel disease. Am J Gastroenterol 2025;120(3):681.
-
- Alsakarneh S, Ahmed M, Azim S, et al. Risk of small intestine cancer in inflammatory bowel disease: A propensity-matched study from a large multi-center database in the United States. Am J Gastroenterol 2024;119(11):2334–7.
-
- Palchuk MB, London JW, Perez-Rey D, et al. A global federated real-world data and analytics platform for research. JAMIA Open 2023;6(2):ooad035.
-
- Wang L, Wang W, Kaelber DC, et al. GLP-1 receptor agonists and colorectal cancer risk in drug-naive patients with type 2 diabetes, with and without overweight/obesity. JAMA Oncol 2024;10(2):256–8.
-
- Alsakarneh S, Desai A, Kochhar GS, et al. Treatment of chronic pouchitis with JAK inhibitors: Results from a large multicenter database. Inflamm Bowel Dis. 2024;izae116. doi:10.1093/ibd/izae116. - DOI
LinkOut - more resources
Full Text Sources
